Michael I. Nishimura

9.7k citations
139 papers · 6.8k · 1 hit paper · h-index 44

Impact in

  • Immunology top 0.2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immune cells in cancer
  • Oncology top 0.5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immunotherapy and Immune Responses 67
    • T-cell and B-cell Immunology 50
    • Immune Cell Function and Interaction 48
    • CAR-T cell therapy research 66
    • Cancer Immunotherapy and Biomarkers 11

Michael I. Nishimura

137 papers receiving 6.7k citations

Michael I. Nishimura's Hit Papers

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy 2008 · 1.0k citations
1.0k0+6+12Years since publication2505007501000

Peers

Michael I. Nishimura
Comparison fields: 5 of 121
  • Immunology 4.5k
  • Oncology 3.1k
  • Genetics 883
  • Molecular Biology 1.8k
  • Hepatology 168
Replace Alan B. Frey with:
Alan B. Frey United States
Kyogo Itoh Japan
Anna Mondino Italy
Werner Held Switzerland
Vincent Ling United States
Clive R. Wood United States
Paolo Dellabona Italy
Chrystal M. Paulos United States
Akio Matsuzawa Japan
Michael I. Nishimura relative to Alan B. Frey United States Alan B. Frey's profile →
Citations per field
00.5×1.5×2.0×
Alan B. Frey · 1×
Citations per year

Countries citing papers authored by Michael I. Nishimura

Since Specialization
Citations

This map shows the geographic impact of Michael I. Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael I. Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael I. Nishimura more than expected).

Fields of papers citing papers by Michael I. Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael I. Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael I. Nishimura. The network helps show where Michael I. Nishimura may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael I. Nishimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael I. Nishimura Line = papers co-authored together Michael I. Nishimura links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
Hit paper breakdown →
20081038
2 1999348
3 2001291
4 2005272
5 2010262
6 2002209
7 1996160
8 1999157
9 2017142
10 2010129
11 2017122
12 2013107
13 199994
14 199788
15 201388
16 200885
17 200783
18
Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen.
199583
19 201182
20 200580

About Michael I. Nishimura

Michael I. Nishimura is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Epidemiology, having authored 139 papers that have together received 6.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (67 papers), CAR-T cell therapy research (66 papers), T-cell and B-cell Immunology (50 papers), Immune Cell Function and Interaction (48 papers), Virus-based gene therapy research (23 papers), Cancer Immunotherapy and Biomarkers (11 papers), vaccines and immunoinformatics approaches (10 papers) and Cytomegalovirus and herpesvirus research (8 papers). The work is most often cited by research in Immunology (4.5k citations), Oncology (3.1k citations), Genetics (883 citations), Molecular Biology (1.8k citations) and Hepatology (168 citations). Michael I. Nishimura has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Elizabeth Garrett‐Mayer, David J. Cole, Mohamed L. Salem, C. Marcela Díaz‐Montero, Alberto J. Montero, Steven A. Rosenberg, Timothy M. Clay, Mary Custer, Suzanne L. Topalian and S A Rosenberg. Their work appears in journals such as Cancer Immunology Immunotherapy, The Journal of Immunology, Journal of Immunotherapy, Cancer Research and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact